121 related articles for article (PubMed ID: 3525527)
1. Human preproapolipoprotein C-II. Analysis of major plasma isoforms.
Fojo SS; Taam L; Fairwell T; Ronan R; Bishop C; Meng MS; Hoeg JM; Sprecher DL; Brewer HB
J Biol Chem; 1986 Jul; 261(21):9591-4. PubMed ID: 3525527
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms.
Lackner KJ; Edge SB; Gregg RE; Hoeg JM; Brewer HB
J Biol Chem; 1985 Jan; 260(2):703-6. PubMed ID: 2981844
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.
Hoeg JM; Meng MS; Ronan R; Fairwell T; Brewer HB
J Biol Chem; 1986 Mar; 261(9):3911-4. PubMed ID: 3005308
[TBL] [Abstract][Full Text] [Related]
4. Rat liver and small intestine produce proapolipoprotein A-I which is slowly processed to apolipoprotein A-I in the circulation.
Sliwkowski MB; Windmueller HG
J Biol Chem; 1984 May; 259(10):6459-65. PubMed ID: 6427215
[TBL] [Abstract][Full Text] [Related]
5. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
Bojanovski D; Gregg RE; Brewer HB
J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
[TBL] [Abstract][Full Text] [Related]
7. Primary structure of the bovine analogues to human apolipoproteins CII and CIII. Studies on isoforms and evidence for proteolytic processing.
Bengtsson-Olivecrona G; Sletten K
Eur J Biochem; 1990 Sep; 192(2):515-21. PubMed ID: 2209608
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II.
Maguire GF; Little JA; Kakis G; Breckenridge WC
Can J Biochem Cell Biol; 1984 Sep; 62(9):847-52. PubMed ID: 6388756
[TBL] [Abstract][Full Text] [Related]
9. A simple micromethod for rapid assessment of the distribution of apolipoprotein C isoforms in very-low-density lipoprotein.
Harake B; Caines PS; Thibert RJ; Cheung RM
Clin Biochem; 1991 Jun; 24(3):255-60. PubMed ID: 1873909
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.
Huff MW; Breckenridge WC; Strong WL; Wolfe BM
Arteriosclerosis; 1988; 8(5):471-9. PubMed ID: 3190554
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
14. Rapid assessment of the distribution of apolipoproteins C-II and C-III subspecies in triglyceride-rich lipoproteins by isoelectric focusing.
Bugugnani MJ; Koffigan M; Kora I; Ouvry D; Clavey V; Fruchart JC
Clin Chem; 1984 Mar; 30(3):349-51. PubMed ID: 6697477
[TBL] [Abstract][Full Text] [Related]
15. [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].
Dergunov AD; Shuvaev VV; Perova NV
Biokhimiia; 1990 Jan; 55(1):134-46. PubMed ID: 2160840
[TBL] [Abstract][Full Text] [Related]
16. Comparative molecular properties of swine and human very low density lipoproteins-apoproteins E and C.
Stucchi AF; Ordovas JM; Shwaery GT; Smith SC
Comp Biochem Physiol B; 1990; 96(1):209-14. PubMed ID: 2364673
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease.
Gordon JI; Sims HF; Lentz SR; Edelstein C; Scanu AM; Strauss AW
J Biol Chem; 1983 Mar; 258(6):4037-44. PubMed ID: 6300070
[TBL] [Abstract][Full Text] [Related]
18. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
Catapano AL; Capurso A; Kinnunen PK
Artery; 1981; 9(2):87-95. PubMed ID: 7295047
[TBL] [Abstract][Full Text] [Related]
19. In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
Biochim Biophys Acta; 1993 Apr; 1167(3):257-63. PubMed ID: 8481386
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
